Indian Drug Inspections In China Lead To 10 Import-License Cancellations
This article was originally published in PharmAsia News
Executive Summary
Indian health officials said inspections of Chinese drug-making facilities exporting to India have led to 10 cancellations of registration certificates and import licenses since the probes began in the past year.